99871 |
The New Frontier: AI in Product Liability Law |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
99864 |
Product Liability in Europe: Understanding and Planning for the EU’s Recent Complaintant Friendly Shift |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
99826 |
PFAS Litigation in the MedTech Industry: Key Cases and Emerging Trends |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
99822 |
New Rule 16.1 on MDLs |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
99818 |
How the toughened up, amended Fed. R. Evid. 702 has been faring |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
99797 |
340B Program: Update on Current Developments |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
99702 |
Pennsylvania points: Navigating the latest employment laws |
|
Live Attendance |
|
1.80 |
0 |
0 |
0.00 |
Add Course |
99539 |
The 2024 Presidential Election – Antitrust Implications for MCOs |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
98498 |
Wage and hour class/collective action |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
97912 |
Investigations and enforcement trends webinar series: key priorities for Q3 2024 |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
96923 |
2024 Virtual Deposition Skills Workshop |
|
Live Attendance |
|
11.70 |
0 |
0 |
0.00 |
Add Course |
96724 |
Recent developments regarding restrictive covenants |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
96163 |
Mid-Year Enforcement Outlook: Key Developments Impacting Health Care and Life Sciences Companies and Investors |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
95643 |
Will It Ever Clear? Navigating a Murky Merger Enforcement Landscape |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
95628 |
Labor & Employment: Best Practices for Conducting Employment Investigations |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
95595 |
2024 Highmark CLE Day |
|
Live Attendance |
|
4.80 |
0 |
0 |
0.00 |
Add Course |
93989 |
Meeting new challenges surrounding data retention |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
93422 |
Unpacking the FTC’s ban on U.S. non-compete agreements |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
92809 |
Managed Care (U.S.): ERISA Basics |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
92637 |
Looking around the corner: What to expect in health and digital advertising privacy |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
92069 |
An explorer’s guide: Using AI tools to find treasure in e-discovery |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
92066 |
Just Say No: The new wave of 340B hospital outpatient drug litigation |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
92015 |
Employment law developments and update |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |
91361 |
The best and worst prescription drug/medical device decisions of 2023 |
|
Live Attendance |
|
1.80 |
0 |
0 |
0.00 |
Add Course |
91360 |
An explorer’s guide: Using AI tools to find treasure in e-discovery |
|
Live Attendance |
|
1.20 |
0 |
0 |
0.00 |
Add Course |